Folgen
Jörg Ellinger
Jörg Ellinger
Universitätsklinikum Bonn
Bestätigte E-Mail-Adresse bei ukbonn.de
Titel
Zitiert von
Zitiert von
Jahr
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence
P Kahl, L Gullotti, LC Heukamp, S Wolf, N Friedrichs, R Vorreuther, ...
Cancer research 66 (23), 11341-11347, 2006
5552006
Circulating microRNAs (miRNA) in serum of patients with prostate cancer
R Mahn, LC Heukamp, S Rogenhofer, A von Ruecker, SC Müller, ...
Urology 77 (5), 1265. e9-1265. e16, 2011
2972011
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels
LM Wulfken, R Moritz, C Ohlmann, S Holdenrieder, V Jung, F Becker, ...
PloS one 6 (9), e25787, 2011
2822011
Global levels of histone modifications predict prostate cancer recurrence
J Ellinger, P Kahl, J Von Der Gathen, S Rogenhofer, LC Heukamp, ...
The Prostate 70 (1), 61-69, 2010
2452010
Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer
I Syring, J Bartels, S Holdenrieder, G Kristiansen, SC Müller, J Ellinger
The Journal of urology 193 (1), 331-337, 2015
2042015
Soy isoflavone genistein in prevention and treatment of prostate cancer
FGE Perabo, EC Von Löw, J Ellinger, A Von Rücker, SC Müller, ...
Prostate Cancer and Prostatic Diseases 11 (1), 6-12, 2008
1782008
Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci
PJ Bastian, J Ellinger, A Wellmann, N Wernert, LC Heukamp, SC Müller, ...
Clinical Cancer Research 11 (11), 4097-4106, 2005
1772005
CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer
J Ellinger, PJ Bastian, T Jurgan, K Biermann, P Kahl, LC Heukamp, ...
Urology 71 (1), 161-167, 2008
1732008
Primitive neuroectodermal tumor: rare, highly aggressive differential diagnosis in urologic malignancies
J Ellinger, PJ Bastian, S Hauser, K Biermann, SC Müller
Urology 68 (2), 257-262, 2006
1652006
CpG island hypermethylation in cell‐free serum DNA identifies patients with localized prostate cancer
J Ellinger, K Haan, LC Heukamp, P Kahl, R Büttner, SC Müller, ...
The Prostate 68 (1), 42-49, 2008
1612008
Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer
J Ellinger, V Wittkamp, P Albers, FGE Perabo, SC Mueller, A von Ruecker, ...
The Journal of urology 181 (1), 363-371, 2009
1432009
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node–negative urothelial carcinoma of …
M May, E Herrmann, C Bolenz, S Brookman-May, A Tiemann, R Moritz, ...
Annals of surgical oncology 18, 2018-2025, 2011
1362011
Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
AR Scheffer, S Holdenrieder, G Kristiansen, A von Ruecker, SC Müller, ...
World journal of urology 32, 353-358, 2014
1342014
Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma
J Ellinger, P Kahl, C Mertens, S Rogenhofer, S Hauser, W Hartmann, ...
International journal of cancer 127 (10), 2360-2366, 2010
1282010
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
J Ellinger, PJ Bastian, KI Haan, LC Heukamp, R Buettner, R Fimmers, ...
International journal of cancer 122 (1), 138-143, 2008
1282008
Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies
J Ellinger, DC Müller, SC Müller, S Hauser, LC Heukamp, A von Ruecker, ...
Urologic oncology: seminars and original investigations 30 (4), 509-515, 2012
1242012
Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma
S Hauser, LM Wulfken, S Holdenrieder, R Moritz, CH Ohlmann, V Jung, ...
Cancer epidemiology 36 (4), 391-394, 2012
1222012
Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker
J Ellinger, P Albers, SC Müller, A Von Ruecker, PJ Bastian
BJU international 104 (1), 48-52, 2009
1192009
H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 …
C Magerl, J Ellinger, T Braunschweig, E Kremmer, LK Koch, T Höller, ...
Human pathology 41 (2), 181-189, 2010
1152010
Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy
J Ellinger, SC Müller, N Wernert, A Von Ruecker, PJ Bastian
BJU international 102 (5), 628-632, 2008
1142008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20